School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, PR China; International Healthcare Innovation Institute (Jiangmen), Jiangmen, 529040, PR China; Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, United Kingdom.
School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, PR China; International Healthcare Innovation Institute (Jiangmen), Jiangmen, 529040, PR China; Bioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
Bioorg Chem. 2021 Feb;107:104580. doi: 10.1016/j.bioorg.2020.104580. Epub 2020 Dec 24.
Research efforts have been directed to the development of oleanolic acid (OA) based α-glucosidase inhibitors and various OA derivatives showed improved anti-α-glucosidase activity. However, the inhibitory effects of indole infused OA derivatives on α-glucosidase is unknown. Herein, we synthesized a series of indole-OA (2a-2o) and -OA methyl ester (3a-3 l) derivatives with various electron withdrawing groups inducted to indole benzene ring and evaluated their anti-α-glucosidase activity. Indole OA derivatives (2a-2o) exhibited superior α-glucosidase inhibitory effects as compared to OA methyl ester derivatives (3a-3l) and OA (with IC values of 4.02 μM-5.30 μM v.s. over 10 μM and 5.52 µM, respectively). In addition, mechanistic studies using biochemical (kinetic assay), biophysical (circular dichroism), and computational (docking) methods revealed that OA-indole derivatives (2a and 2f) are mixed type of α-glucosidase inhibitors and their inhibitory effects were attributed to their capacity of forming the ligand-enzyme complex with α-glucosidase enzyme. Findings from this study support that OA indole derivatives are promising α-glucosidase inhibitors as a potential management of diabetes mellitus.
研究人员致力于开发齐墩果酸(OA)为基础的α-葡萄糖苷酶抑制剂,各种 OA 衍生物表现出改善的抗α-葡萄糖苷酶活性。然而,吲哚注入 OA 衍生物对α-葡萄糖苷酶的抑制作用尚不清楚。在此,我们合成了一系列具有不同吸电子基团诱导到吲哚苯环的吲哚-OA(2a-2o)和-OA 甲酯(3a-3l)衍生物,并评估了它们的抗α-葡萄糖苷酶活性。与 OA 甲酯衍生物(3a-3l)和 OA(IC 值分别为 4.02μM-5.30μM 和 5.52µM)相比,吲哚-OA 衍生物(2a-2o)表现出优越的α-葡萄糖苷酶抑制作用。此外,使用生化(动力学测定)、生物物理(圆二色性)和计算(对接)方法进行的机制研究表明,OA-吲哚衍生物(2a 和 2f)是 α-葡萄糖苷酶的混合类型抑制剂,其抑制作用归因于它们与α-葡萄糖苷酶形成配体-酶复合物的能力。这项研究的结果支持 OA 吲哚衍生物是有前途的α-葡萄糖苷酶抑制剂,可作为糖尿病管理的潜在手段。